Short answer
Pediatrix Medical Group, Inc. (MD) filed its Q3 2026 10-Q quarterly report on Oct 29, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $501M (up 1.7% year over year) with net income of $47M.
Q3 2026 key financials · XBRL
- Revenue
- $501M
- +1.7% YoY · +2.8% QoQ
- Net income
- $47M
- −34.5% YoY · +17.9% QoQ
- Operating margin
- 13.0%
- EPS (diluted)
- $0.58
- −31.0% YoY · +18.4% QoQ
Source: XBRL data from the Pediatrix Medical Group, Inc. (MD) Q3 2026 10-Q on SEC EDGAR. USD.
Pediatrix Medical Group, Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $501.4M, up 1.7% YoY from $492.9M, driven by acquisitions and same-unit growth
- Operating margin 13.0% vs 13.8% YoY; net income $47.0M vs $71.7M
- Maternal-fetal medicine volumes increased; newborn nursery volumes declined
- Cash $311.9M vs $375.2M at December 31, 2025; operating cash flow $114.5M vs $160.1M
- Stock repurchases $147.2M; Medicaid reforms, NSA changes and 2027 Medicare fee reduction of 1.19% as headwinds
Risk Factors
- No material changes to risk factors disclosed in the 2025 Form 10-K
- Carried-forward regulatory risk, healthcare laws and regulations could affect operations
- Carried-forward operational risk, physician recruitment and retention could constrain services
- Carried-forward financial risk, reimbursement pressure could reduce revenue and margins
- Share-repurchase risk, $21.5 million remaining under the August 2025 program subject to market conditions
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Pediatrix Medical Group, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.